当前位置: 首页 > 期刊 > 《心脑血管病防治》 > 2011年第6期
编号:12148153
经皮室间隔化学消融治疗肥厚型梗阻性心肌病疗效观察(3)
http://www.100md.com 2011年12月1日 《心脑血管病防治》 2011年第6期
     [8]Knight C, Kurbaan AS, Seggewiss H, et al. Nonsurgical septal reduction f or hypertrophic obstructive cardiomyopathy: outcome in the first series of pati ents[J].Circulation,1997,95(8):2075-2081.

    [9]易建华,陶谦明,陈君柱,等.肥厚梗阻型心肌病化学消融术中、术后严重并发症及防 治[J].中国循环杂志,2002,17(6):448-450.

    [10]Maron BJ, Nishimura RA, Mckenna WJ, et al. Assessment of permanent dualc hamber pacing as a treatment for drug_refractory symptomatic patients with obst ructive hypert ropic cardiomyopathy. A randomized double_blind, crossover study (M_PATHY)[J].Circulation,1999,99(22):2927-2933.

    [11]Eselka J, Prochazkova S, Duchonova R, et al. Alcohol septal ablation f or hypertrophic obstructive cardiomyopathy:lower alcohol dose reduces size of i nfarction and has comparable hemodynamic and clinical out come[J].Catheter Car diovasc Interv,2004,63(2):231-235.

    [12]Su Min Chang, Nasser M, Lakkis, et al. Predictors of Outcome After Alco hol Septal Ablation Therapy in Patients with Hypertrophic Obstmctive Cardiomyopa thy[J].Circulation,2004,109(7):824-827., 百拇医药(陈严 傅国胜)
上一页1 2 3